Synonyms: Anti-Protein kinase C- like 1; Anti-Protein kinase C-like PKN; Anti-Protein kinase PKN-alpha; Anti-Protein-kinase C-related kinase 1; Anti-Serine-threonine protein kinase N; Anti-Serine/threonine-protein kinase N1
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: Serine/threonine-protein kinase N1 is an enzyme encoded by the PKN1 gene in humans and is mapped to chromosome 19p12-p13.1. It inhibits Wnt/ß-catenin signaling and sensitizes melanoma cells to cell death stimulated by WNT3A. It is found in various malignancies and may have a role in ovarian cancer development or progression. It is involved in the regulation of intermediate filaments of the actin cytoskeleton. It also has effects on processes as diverse as mitotic timing and apoptosis.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC